Provided by Tiger Trade Technology Pte. Ltd.

Vertex, Inc.

13.48
-0.3500-2.53%
Post-market: 13.38-0.1000-0.74%18:11 EDT
Volume:1.39M
Turnover:18.81M
Market Cap:2.18B
PE:611.66
High:14.09
Open:13.72
Low:13.38
Close:13.83
52wk High:26.54
52wk Low:10.21
Shares:162.00M
Float Shares:70.89M
Volume Ratio:1.11
T/O Rate:1.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0220
EPS(LYR):0.0444
ROE:1.46%
ROA:0.65%
PB:9.06
PE(LYR):303.63

Loading ...

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
1 hour ago

Evercore ISI Adjusts Vertex Pharmaceuticals Price Target to $600 From $535, Maintains Outperform Rating

MT Newswires Live
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) and Medtronic (MDT)

TIPRANKS
·
Yesterday

Vertex Pharmaceuticals Price Target Announced at $665.00/Share by Morgan Stanley

Dow Jones
·
Yesterday

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Yesterday

What Does Crinetics Pharmaceuticals (CRNX) Delisting Mean After The Takeover Closed?

Simply Wall St.
·
Yesterday

Vertex Pharmaceuticals resumed with an Overweight at Morgan Stanley

TIPRANKS
·
Yesterday

Vertex Pharmaceuticals Closes Crinetics Pharmaceuticals Acquisition

MT Newswires Live
·
Sep 01

Vertex Pharmaceuticals completes acquisition of Crinetics Pharmaceuticals

TIPRANKS
·
Sep 01

Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs

TIPRANKS
·
Sep 01

Vertex Advances Share Buyback, Acquires 445,500 Shares by August

TIPRANKS
·
Sep 01

Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run

Simply Wall St.
·
Sep 01

Crinetics Shareholders Approve Vertex Acquisition at Special Meeting

TIPRANKS
·
Aug 29

Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors

TIPRANKS
·
Aug 29

Vertex Corp. Added to JPX-Nikkei Mid and Small Cap Index for FY2026

TIPRANKS
·
Aug 27

Vertex Corp. Refines Leadership Structure at Key Subsidiary Vertex Co.

TIPRANKS
·
Aug 27

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 27

Vertex Highlights Fy2025 Revenue of $748M in Investor Presentation on Intelligent Tax Compliance Platform

Reuters
·
Aug 27

Viavi Solutions (VIAV) Could Be 40% Undervalued On Vertex 6.0 Launch

Simply Wall St.
·
Aug 25